SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-035098
Filing Date
2023-10-03
Accepted
2023-10-02 20:20:45
Documents
14
Period of Report
2023-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48472
2 SIDE LETTER ex10-1.htm EX-10.1 20054
  Complete submission text file 0001493152-23-035098.txt   297564

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocea-20231002.xsd EX-101.SCH 3865
4 XBRL DEFINITION FILE ocea-20231002_def.xml EX-101.DEF 27188
5 XBRL LABEL FILE ocea-20231002_lab.xml EX-101.LAB 37603
6 XBRL PRESENTATION FILE ocea-20231002_pre.xml EX-101.PRE 25809
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5698
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 231301290
SIC: 2834 Pharmaceutical Preparations